ALFA FinderBSE filing, NSE: KIMS. Summary written from the filing by ALFA Finder's alert engine.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹726.15
- Market cap
- ₹30,499 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 143.6×Sector 54.5×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Earnings Call Transcript: Key Takeaways
KIMS delivered strong revenue growth led by Kondapur's rapid ramp-up, despite temporary margin compression from new oncology programs.
Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Krishna Institute of Medical Sciences Management Change
KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.
- Execution
- 5 years
Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways
Q2 FY27 total revenue Rs13,630 Mn (+41.3% YoY), EBITDA Rs2,789 Mn (20.5% margin), PAT Rs757 Mn (+5.1% YoY). Expansion via 700+ beds planned.
Krishna Institute of Medical Sciences Results Update
KIMS reported Q2 FY27 consolidated revenue of Rs 1,363 Crore, up 41.3% YoY, with PAT of Rs 76 Crore. EBITDA rose 34% YoY to Rs 279 Crore.
Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.6 Cr · +3.6% YoY
Other share pledge announcements
All →Embassy Developments Share Pledge
Embassy Developments' promoter group released and re-pledged shares, with transactions worth Rs.1,021.64 Crore. Pledge activity increases promoter encumbrance for investors to monitor.
- Value
- ₹1,022 Cr
Aequs Share Pledge
Aequs promoter Melligeri Private Family Foundation released a pledge over 14.99% of shares. The revised disclosure concerns a release effected on 8 October 2026.
Embassy Developments Share Pledge
Catalyst Trusteeship disclosed release and re-creation of a pledge over 5.35 crore Embassy Developments shares. No additional pledge or borrowing was created.
MosChip Technologies Share Pledge
Mayuka Holdings, a Moschip promoter, pledged 2,57,80,011 shares (13.21%) to Infina Finance for a Rs 150 Crore loan. The pledge is a revised Regulation 31(1) disclosure.
- Value
- ₹150.0 Cr
Master Trust Share Pledge
Promoter Harneesh Kaur Arora created a pledge over 66,35,000 Master Trust shares (5.40%) to secure Rs 75 crore NCDs of subsidiary Master Capital Services. Promoter encumbrance rises to 20.81% of the company.
- Value
- ₹75.00 Cr
Master Trust Share Pledge
Master Trust promoters Parveen Singhania and Harneesh Kaur Arora pledged 66.35 lakh shares each. The pledge is valued at Rs 51.44 Crore.
- Value
- ₹51.44 Cr